Using an experimental murine system and CT26 tumor cells, depletion of CD25high Treg cells has been shown to allow the host to induce both CD4+ and CD8+ anti-tumor responses following tumor challenge. The capacity of the host to mount this anti-tumor response is lost once the number of CD25high Treg cells is restored over time. The gene discussed is CD4; the disease is neoplasm.